LEVOSIMENDAN FOR USE IN TREATING CHRONIC VALVULAR DISEASE

摘要

Disclosed is a method for the treatment of chronic valvular disease (CVD), also referred to as myxomatous degenerative valve disease, in a non-human animal, in particular dogs. The method comprises administering to a non-human animal subject in need thereof an effective amount of levosimendan - systematic name ({ 4-[(4'R)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl]phenyl} hydrazono)propanedinitrile - or a pharmaceutical acceptable salt thereof.